Women and cardiovascular disease

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 6, 2007, Pages 791-793

  Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA;

BLOOD CLOT LYSIS; CANADA; CORONARY ARTERY BYPASS GRAFT; DISEASE PREDISPOSITION; EXERCISE TEST; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MORTALITY; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PUBLICATION; SEX DIFFERENCE; UNITED STATES;

EID: 33947407686     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.061677     Document Type: Note

References (9)

1. Winn HN, Dellsperger K, editors. Cardiovascular disease in women. London (UK): Informa Healthcare; 2006.
2. Wenger NK, Collins P, editors. Women and heart disease. 2nd ed. London (UK): Taylor & Francis; 2005.
3. Shaw LJ, Redberg RF, editors. Coronary disease in women: evidence-based diagnosis and treatment. Totowa (NJ): Humana Press; 2004.
4. Pilote L, Dasgupta K, Guru V, et al. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007;176(Supp 1):S1-44. Available: www.cmaj.ca/cgi/content/full/176/6/S1
5. Levi F, Lucchini F, Negri E, et al. Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002;88:119-24.
6. Gao W, Qiao Q, Tuomilehto J. Post-challenge hyperglycaemia rather than fasting hyperglycaemia is an independent risk factor of cardiovascular disease events. Clin Lab 2004;50:609-15.
7. Arslanian-Engoren C, Patel AM, Fang J, et al. Symptoms of men and women presenting with acute coronary syndromes. Am J Cardiol 2006;98:1177-81.
8. Fetters JK, Peterson ED, Shaw LJ, et al. Sex-specific differences in coronary artery disease risk factors, evaluation, and treatment: Have they been adequately evaluated? Am Heart J 1996;131:796-813.
9. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352: 1293-304.